| 영문 | advanced cancer | 한글 | 진행암 |
|---|---|---|---|
| 설명 | 조기암에 대한 말로 암의 경과가 진행된 것을 말한다. |
||
| 영문 | lung cancer | 한글 | 폐암 |
|---|---|---|---|
| 설명 | 허파에 생기는 악성종양이다. 가장 예후가 나쁜 종양중의 하나로써 조기발견이 어렵고 증세 또한 늦게 나타나서, 그 종양의 종류에 따라 다르나 치료후에도 대개 8%만이 5년 생존이 가능한 악성종양이다. 유발인자로는 대표적으로 담배가 알려져 있으며, 유전적인 요소도 어느 정도 기여하는 것으로 알려져 있다. |
||
| 영문 | cancer chemotherapy | 한글 | 항암화학요법 |
|---|---|---|---|
| 설명 | 화학적 물질을 이용하여 암을 치료하는 것을 말한다. 이때 사용되는 물질을 항암제라고 한다. 이상적인 항암제는 정상적인 세포에는 이상이 없고 단지 암세포에만 치명적인 효과를 나타내어야 한다. 이렇게 하려면 암세포만의 특이한 특성을 이해하고 그곳에만 작용하는 약물을 개발하여야 한다. 최근 대부분의 항암제는 암세포가 정상 세포에 비하여 월등히 증식을 빨리한다는 특성을 이용하고 있다. 증식이 빠르다는 것은 유전정보를 가지고 있는 DNA의 복제가 빠르다는 것을 의미한다. 만약 DNA의 복제를 방해한다면 증식이 아주 빠른 암세포에게는 치명적이지만 영원히 증식을 하지 않는(DNA의 복제가 거의 필요없는)신경세포나 증식이 암세포에 비해서 아주 느린 정상세포에서는 거의 영향을 주지 못한다. 하지만 신체에서도 정상적으로 증식이 암세포와 비슷한 수준으로 일어나는 세포가 있는데 그것은 머리카락을 만드는 모낭세포와 소화관의 점막을 이루는 세포와 혈액의 세포를 만드는 골수 세포이다. 그러므로 항암제를 사용할 경우 이런 세포가 암세포와 마찬가지로 치명적인 영향을 입을 것은 당연하다(그래서 항암제 치료시엔 머리가 빠지고 소화불량이 잘온다). |
||
| AJKD | American Journal of Kidney Diseases |
|---|---|
| JOC | Journal of Oncologic Clinical(?) |
| AEM | Academic Emergency Medicine [journal]; analytical electron microscopy; ambulatory electrocardiograph... |
| AM | Academic Medicine [journal]; actomyosin; acute myelofibrosis; adult male; adult monocyte; aerospace ... |
| BMJ | bones, muscles, joints; British Medical Journal |
| Indian tick typhus | A febrile disease of the mediterranean area, the crimea, africa, and india, caused by infection with rickettsia conorii. (12 Dec 1998) |
|---|---|
| united states indian health service | A division of the united states public health service that is responsible for the public health and the provision of medical services to native american indian populations in the united states, primarily those residing on reservation lands. (12 Dec 1998) |
| American Cancer Society | <address, organisation> American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA. Tel: 00 1 404 320-3333 (05 Feb 1998) |
| bladder cancer | The most common warning sign of bladder cancer is blood in the urine. The diagnosis of bladder cancer is supported by findings in the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). Treatment of bladder cancer depends on the growth, size, and location of the tumour. (12 Dec 1998) |
| bladder cancer risks | Smoking is a major risk factor. Cigarette smokers develop bladder cancer 2-3 times more often than do nonsmokers. Quitting smoking reduces the risk of bladder cancer, lung cancer, several other types of cancer, and a number of other diseases as well. Workers in some occupations are at higher risk of developing bladder cancer because of exposure to carcinogens (cancer-causing substances) in the workplace. These workers include people in the rubber, chemical, and leather industries, as well as hairstylists, machinists, metal workers, printers, painters, textile workers, and truck drivers. (12 Dec 1998) |
| bone cancer | <oncology> A general term to imply malignant tumour growth in bone. (27 Sep 1997) |
| bovine cancer eye | A malignant squamous cell carcinoma of cattle, especially the Hereford breed, that originates in the conjunctival mucous membranes or the surrounding skin; it occurs principally in range cattle having unpigmented skin around the eye and living in regions of intense sunlight. (05 Mar 2000) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
| breast cancer | <oncology> The uncontrolled growth of malignant breast tissue. Breast cancer is currently the most common cancer in women and the leading cause of cancer-related death in the 15-54 age group. Strong risk factors include a prior history for breast cancer or a positive family history for breast cancer. Early detection is possible through the use of monthly breast self-examination, annual clinical exams and mammography. WWW: cancerNET document for patients WWW: cancerNET document for clinicians (05 Jan 1998) |
| breast cancer susceptibility genes | Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered. (12 Dec 1998) |
| buyo cheek cancer | betel cancer |
| cancer | <oncology> The first historical description of this condition was in relation to breast carcinoma. This is now a general term for more than 100 diseases that are characterised by uncontrolled, abnormal growth of cells. Cancer cells can spread locally or through the bloodstream and lymphatic system to other parts of the body. (18 Nov 1997) |
| cancer antigen 125 test | Test for cell-surface antigen found on derivatives of coelomic epithelium. Elevated levels of this antigen are associated with ovarian malignancy and benign pelvic disease such as endometriosis. (05 Mar 2000) |
| cancer, bladder | Cancer of the organ responsible for temporarily holding urine after it leaves the kidneys. The most common warning sign of cancer in the bladder (the hollow organ in the lower abdomen that stores urine) is blood in the urine. The diagnosis of bladder cancer is supported by findings of the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). (12 Dec 1998) |
| cancer bodies | Discrete, acidophilic or amphophilic, hyaline body's of various shapes and sizes, occurring in the cytoplasm of some of the neoplastic cells and also extracellularly in the stroma of various carcinomas and sarcomas; formerly regarded by some observers as parasitic causal agents, but now thought to be products of cell necrosis (apoptosis). (05 Mar 2000) |